Enzyme Venture Capital

Enzyme Venture Capital operates as a venture capital firm, providing equity capital to early-stage technology companies. It focuses on identifying and supporting growth across the technology, internet, and media sectors. The firm employs a strategic investment approach, connecting promising ventures with essential financial backing.

Enzyme Venture Capital originates from Daniel Nofal's vision, identifying significant untapped potential for capital flow between Latin American and US entrepreneurial ecosystems. The firm positions itself as a robust two-way bridge, facilitating investment and knowledge exchange for technology-focused projects. Nofal’s background informs its cross-border investment thesis.

The firm serves start-up companies seeking seed and early-stage funding, particularly those benefiting from a dual-market strategy. Enzyme Venture Capital envisions itself as a pivotal facilitator in the global tech landscape, fostering innovation and entrepreneurship by linking diverse markets. Its objective involves cultivating a dynamic portfolio bridging geographical and investment divides.